| Name | Title | Contact Details |
|---|---|---|
Charles Bodner |
Executive Vice President and Chief Operating Officer | Profile |
Gavin Nichols |
Chief Information Officer and Executive Vice President of Technology | Profile |
Gavin Nichols |
Chief Information Officer and Executive Vice President of Technology | Profile |
Andrew Masters |
Chief Technology Officer | Profile |
Michael Anderson |
Senior Director of Corporate Information Technology | Profile |
APC, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Ankeny, IA. To find more information about APC, Inc., please visit www.amerprotcorp.com
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
Harken Health is a new kind of health care company that unites relationship-based primary care with a range of competitively priced insurance plan options. Our care approach is rooted in the values of a simpler time when the doctor-patient relationship mattered. Harken Health Care Teams are empowered with the time to listen and build authentic, compassionate, trusting relationships with members. Our model enables us to remove many of the barriers that often get in the way of delivering exceptional care. Strong relationships and a home base for primary care have been shown to improve patient satisfaction and lower overall medical costs. Harken is simplifying and improving the health care experience by combining our unique care approach with flexible insurance coverage. Harken Health membership includes unlimited primary care visits to Harken’s modern and inviting Harken Health Centers, complimentary health coaching, integrated behavioral health specialists, wellness classes, and 24-hour, 7-days a week access to a Harken Health doctor by phone. You`ll have access to your Care Team via office visit, phone, email or video chat. Members also have access to an expansive nationwide network of leading hospitals, specialists and other clinics. Harken Health has 10 Care Centers in the Atlanta, GA and Chicago, IL metro markets, with plans to expand to more communities soon. At Harken our goal is clear – “To change what the world expects from health care, one community at a time.”
NueHealth is building a nationwide system of clinically integrated provider networks that puts healthcare into the hands of consumers. With a vast network of purpose-driven surgical centers and hospitals, NueHealth connects providers directly to consumers and aids them in delivering value-based payment options and improved outcomes. To deliver this improved value, NueHealth leverages proprietary technologies, online platforms, bundled payments and targeted programs and services. NueHealth gives providers and payors the tools and resources to stay ahead of healthcare’s continued evolution, while giving employers, insurance companies and patients access to a simplified model and affordable, high-quality, streamlined care.